Literature DB >> 8386441

High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of HIV-associated Hodgkin's disease.

B G Herndier1, H C Sanchez, K L Chang, Y Y Chen, L M Weiss.   

Abstract

The Epstein-Barr virus (EBV) has been implicated in the pathogenesis of Hodgkin's disease, with an frequency of 15 to 50% in the immunocompetent host. We studied 12 formalin-fixed, paraffin-embedded cases of Hodgkin's disease occurring in human immunodeficiency virus-infected individuals to determine the frequency of EBV in Hodgkin's disease from this population. EBV DNA-RNA in situ hybridization was performed using a 30-base biotinylated anti-sense oligonucleotide complementary to the EBER1 gene of EBV. EBV RNA was found in the Reed-Sternberg cells and variants in 11 of 12 cases. Double-labeling studies confirmed the presence of EBV RNA in CD15-expressing Hodgkin's cells in all 11 cases, although rare B lymphocytes coexpressing EBV RNA and CD20 were also noted in these cases. The Hodgkin's cells in all 11 EBER-positive cases expressed latent membrane protein. The one case negative for EBV RNA showed the histology of nodular, lymphocyte predominance, a subtype thought to be distinct from other types of Hodgkin's disease.

Entities:  

Mesh:

Year:  1993        PMID: 8386441      PMCID: PMC1886872     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  32 in total

1.  Detection of immunoglobulin light-chain mRNA in lymphoid tissues using a practical in situ hybridization method.

Authors:  L M Weiss; L A Movahed; Y Y Chen; S S Shin; R M Stroup; N Bui; P Estess; J M Bindl
Journal:  Am J Pathol       Date:  1990-10       Impact factor: 4.307

2.  Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells.

Authors:  H Herbst; F Dallenbach; M Hummel; G Niedobitek; S Pileri; N Müller-Lantzsch; H Stein
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

3.  Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease.

Authors:  L M Weiss; L A Movahed; R A Warnke; J Sklar
Journal:  N Engl J Med       Date:  1989-02-23       Impact factor: 91.245

4.  High frequency of Epstein-Barr virus genome detection in Hodgkin's disease of HIV-positive patients.

Authors:  S Uccini; F Monardo; A Stoppacciaro; A Gradilone; A M Aglianò; A Faggioni; V Manzari; L Vago; G Costanzi; L P Ruco
Journal:  Int J Cancer       Date:  1990-10-15       Impact factor: 7.396

5.  Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease.

Authors:  G Pallesen; S J Hamilton-Dutoit; M Rowe; L S Young
Journal:  Lancet       Date:  1991-02-09       Impact factor: 79.321

6.  High incidence of Epstein-Barr virus genomes in Hodgkin's disease.

Authors:  H Herbst; G Niedobitek; M Kneba; M Hummel; T Finn; I Anagnostopoulos; M Bergholz; G Krieger; H Stein
Journal:  Am J Pathol       Date:  1990-07       Impact factor: 4.307

7.  Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization.

Authors:  I Anagnostopoulos; H Herbst; G Niedobitek; H Stein
Journal:  Blood       Date:  1989-08-01       Impact factor: 22.113

8.  AIDS-associated polyclonal lymphoma: identification of a new HIV-associated disease process.

Authors:  M S McGrath; B Shiramizu; T C Meeker; L D Kaplan; B Herndier
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1991

9.  Epstein-Barr virus in benign lymph node biopsies from individuals infected with the human immunodeficiency virus is associated with concurrent or subsequent development of non-Hodgkin's lymphoma.

Authors:  D Shibata; L M Weiss; B N Nathwani; R K Brynes; A M Levine
Journal:  Blood       Date:  1991-04-01       Impact factor: 22.113

10.  Detection of Epstein-Barr virus messenger RNA in Reed-Sternberg cells of Hodgkin's disease by in situ hybridization with biotinylated probes on specially processed modified acetone methyl benzoate xylene (ModAMeX) sections.

Authors:  P Brousset; S Chittal; D Schlaifer; J Icart; C Payen; F Rigal-Huguet; J J Voigt; G Delsol
Journal:  Blood       Date:  1991-04-15       Impact factor: 22.113

View more
  7 in total

1.  Latent membrane protein 1 deletion mutants accumulate in reed-sternberg cells of human immunodeficiency virus-related Hodgkin's lymphoma.

Authors:  Massimo Guidoboni; Maurilio Ponzoni; Laura Caggiari; Antonia A Lettini; Luca Vago; Valli De Re; Annunziata Gloghini; Paola Zancai; Antonino Carbone; Mauro Boiocchi; Riccardo Dolcetti
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

2.  Differences in Virological and Immunological Risk Factors for Non-Hodgkin and Hodgkin Lymphoma.

Authors:  Leah Shepherd; Lene Ryom; Matthew Law; Camilla Ingrid Hatleberg; Stephane de Wit; Antonella d'Arminio Monforte; Manuel Battegay; Andrew Phillips; Fabrice Bonnet; Peter Reiss; Christian Pradier; Andrew Grulich; Caroline Sabin; Jens Lundgren; Amanda Mocroft
Journal:  J Natl Cancer Inst       Date:  2018-06-01       Impact factor: 13.506

Review 3.  Hodgkin lymphoma in patients with HIV infection: a review.

Authors:  Nihal Martis; Nicolas Mounier
Journal:  Curr Hematol Malig Rep       Date:  2012-09       Impact factor: 3.952

Review 4.  How I treat classical Hodgkin lymphoma in patients infected with human immunodeficiency virus.

Authors:  Thomas S Uldrick; Richard F Little
Journal:  Blood       Date:  2014-12-11       Impact factor: 22.113

Review 5.  Epstein-Barr virus and Hodgkin's disease.

Authors:  L M Weiss
Journal:  Curr Oncol Rep       Date:  2000-03       Impact factor: 5.945

6.  CD68-positive tumour associated macrophages, PD-L1 expression, and EBV latent infection in a high HIV-prevalent South African cohort of Hodgkin lymphoma patients.

Authors:  Katherine Antel; D Chetty; J Oosthuizen; Z Mohamed; L Van der Vyver; E Verburgh
Journal:  Pathology       Date:  2021-02-06       Impact factor: 5.335

7.  Blood Epstein-Barr virus DNA does not predict outcome in advanced HIV-associated Hodgkin lymphoma.

Authors:  Ikram Ul-Haq; Alessia Dalla Pria; Elisa Suardi; David J Pinato; Fieke Froeling; John Forni; Paul Randell; Mark Bower
Journal:  Med Oncol       Date:  2018-03-13       Impact factor: 3.064

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.